Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Fortress Biotech Inc.

http://www.fortressbiotech.com

Latest From Fortress Biotech Inc.

Tech Transfer Roundup: Inside The Law That Transformed The Research Landscape

The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.

Deals Business Strategies

Cipla Propels 'Lung Leadership' Plans

Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.

Strategy Sales & Earnings

Cipla Propels Lung Leadership Plans, Reimagines Operating Models

Cipla’s fourth-quarter 2020 sales were hit because of COVID-19- related dispatch challenges, though it remains upbeat about the prospects of interchangeable albuterol and the latest filing for generic Advair Diskus as part of its quest for lung leadership.

Commercial Sales & Earnings

Finance Watch: Ayala Launches First Biopharma IPO In May

The cancer drug developer raised $55m. Also, Lyra raised $56m in the last of four biopharma IPOs in April, Biogen sold $3bn worth of debt, Oberland raised a $1.05bn fund and Praxis launched with more than $100m. 

Financing Innovation
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Aevitas Therapeutics, Inc.
    • Altamira Bio
    • Avenue Therapeutics, Inc. (ATXI)
    • Baergic Bio, Inc.
    • Caelum Biosciences Inc.
    • Cellvation, Inc.
    • Checkpoint Therapeutics, Inc.
    • Coronado Biosciences, Inc. (CNDO)
    • Cyprium Therapeutics, Inc.
    • DiaVax Biosciences
    • Helocyte, Inc.
    • Journey Medical Corporation (JMC)
    • Mustang Bio, Inc.
    • Mustang Therapeutics, Inc. (MBIO)
    • National Holdings Corporation
    • Oncogenuity, Inc.
    • Tamid Bio, Inc.
UsernamePublicRestriction

Register